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ABSTRACT
Objective: The objective of the present study was to formulate the effervescent floating matrix tablet of metronidazole and to evaluate the effect of 
varying concentrations of hydrophilic polymers on drug release.
Methods: Drug excipients interaction was studied by Fourier transform infrared spectrophotometer. The effervescent floating matrix tablets 
were prepared by direct compression technique using hydroxypropyl methylcellulose (HPMCK4) and xanthan gum alone and in combination as 
release retardants. Microcrystalline cellulose was used as diluent. Sodium bicarbonate was used as effervescent agent. The prepared matrix tablets 
were evaluated for their physicochemical parameters such as weight variation, hardness, friability, content uniformity, buoyancy time, and in vitro 
dissolution.
Results: Micromeritic properties and post-compression parameters were evaluated and all the parameters were found within the acceptable limit. 
The drug release data were subjected to different models to evaluate release kinetics and mechanism of drug release. The matrix tablets prepared 
with xanthan gum and a mixture of xanthan gum and HPMCK4 were retarded the drug release up to 12 h. The release mechanism of metronidazole 
was evaluated on the basis of release exponent n value in Peppas model. The n value of the formulations ranged from 0.46 to 0.89 which indicated 
Case II transport and zero-order release.
Conclusion: Floating matrix tablet is the simple, efficient, and economic method to sustain the release of metronidazole to eradicate Helicobacter pylori 
in peptic ulcer disease.
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INTRODUCTION
Oral route is the most convenient route for the drug delivery due to low 
cost of the therapy, ease of administration leads to high level of patient 
compliance and flexibility in the designing of dosage form. Novel oral 
drug delivery systems classified into oral controlled release dosage 
forms (OCRDFs) and targeting dosage forms [1]. Variable and short 
gastric residence time results in decreased efficacy of the administered 
dose when administered in the form of OCRDF. To improve the 
performance of OCRDF, a new concept was discovered by scientists in 
drug delivery that is gastroretentive drug delivery systems (GRDDSs). 
A GRDDS can be defined as a system which remains in the stomach for a 
sufficient time period against all the physiological barriers, releasing the 
active moiety in a controlled manner and finally becomes metabolized 
in the body. Gastroretentive drug delivery system can be a useful tool 
in delivery of drugs that are primarily absorbed in the duodenum that 
is upper part of the gastrointestinal tract [2]. Floating drug delivery 
is the class of targeted oral drug delivery system. A floating drug 
delivery system floats in the gastric juice without affecting the gastric 
emptying rate. This technique can provide therapeutically effective 
plasma drug concentration for longer durations, thereby reducing 
the dosing frequency and minimizing fluctuations and also helps to 
increase a drug’s gastric residence time and reduces the variability in 
bioavailability [3].
Helicobacter pylori (Campylobacter pylori) is a Gram-negative, 
microaerophilic bacterium, usually found in the stomach or the upper 
part of the small intestine. H. pylori infection is a common worldwide 
infection that is an important cause of peptic ulcer disease and gastric 
cancer. Peptic ulcers are sores that develop in the lining of the stomach 
(gastric ulcers), lower esophagus (esophageal ulcers), and/or first part 
of the small intestine (duodenal ulcers), as a result of inflammation 
caused by the bacteria H. pylori, erosions, and stomach acids. American 
College of Gastroenterology guidelines, 2017 for the treatment of 
H. pylori infection includes the following therapeutic strategies for the 
first-line treatment, bismuth, proton-pump inhibitors, tetracyclines, and 
a nitroimidazole (strong recommendation), particularly in those with 
previous macrolide exposure or are penicillin allergic [4]. Nitroimidazole 
(metronidazole) antibiotics are most active antibiotics for the 
treatment and prevention of infections caused by anaerobic bacteria. 
Metronidazole is used as an antibiotic, amebicide, and antiprotozoal 
agent. Metronidazole used for preparing floating tablets, to retain in the 
stomach, because it is locally active in the gastric mucosa. The prolonged 
effect of locally active metronidazole increases its clinical efficacy for 
better eradicating H. pylori in peptic ulcer disease [5-9].
Drug release from the matrix tablets was controlled by the polymer 
properties and its structure. Hydrophilic polymers are one of the 
most commonly used drug release retardants in matrix tablets. 
Hydroxypropyl methylcellulose (HPMCK4) is a semi-synthetic water-
soluble cellulose derivative. It has been widely used in the development 
of sustained release dosage forms. Natural gums are inert and non-toxic. 
Xanthan gum is a natural, biosynthetic, edible, and high-molecular-
weight gum. Xanthan gum is an extracellular polysaccharide produced 
by fermentation of carbohydrate with Xanthomonas campestris bacteria, 
is hydrophilic swellable polymer. The primary structure of xanthan gum 
consists of 1, 4 linked β-D-glucose residues, having a trisaccharide side 
chain of β-D-mannose-β-D-glucuronic acid-α-D-mannose attached to 
alternate D-glucose units of the main chain. The anionic character of 
this polymer is due to the presence of both glucuronic acid and pyruvic 
acid groups in the side chain. It develops a weak structure in water 
which creates high viscosity solutions at low concentration [10,11].
The objective of the present study was to prepare the effervescent 
floating matrix tablets of metronidazole using hydrophilic polymers 
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such as hydroxypropyl methylcellulose, xanthan gum alone, and in 
combination. Sodium bicarbonate was used as gas generating agent 
to float and to achieve sustained release of metronidazole to eradicate 
H. pylori in the treatment of peptic ulcer.
MATERIALS AND METHODS
Materials
Metronidazole was purchased from Yarrow Chemical Ltd., 
Mumbai, India. Xanthan gum, hydroxypropyl methylcellulose K4M, 
microcrystalline cellulose, and sodium bicarbonate were purchased 
from Vijaya Enterprises Ltd., Hyderabad, India; magnesium stearate 
and talc were purchased from Aman Scientific Traders, Vijayawada, 




Infrared spectra of the pure drug and drug with polymers were 
recorded on a Fourier transform infrared spectrophotometer. The 
disc method was employed to study possible interactions between 
drug and selected polymers. Infrared spectrum was taken by 
scanning the sample in KBr (IR grade) discs and analyzed over a 
wavenumber range of 4000–400 cm−1. Transmittance spectra were 
recorded.
Preparation of floating matrix tablets
Floating matrix tablets of metronidazole were prepared by direct 
compression technique. All the ingredients were individually screened 
through sieve no. 60 except glidant and lubricant. Required quantities 
of metronidazole, polymer, diluents, and sodium bicarbonate were 
accurately weighed according to the composition shown in Table 1 
and mixed in a polybag for about 30–45 min. The obtained blend 
was lubricated with talc and magnesium stearate for another 5 min, 
and then, the resultant mixture was directly compressed into tablets 
with 12 mm flat faced circular punches using 12-station rotary tablet 
machine (CEMACH, Ahmedabad, India) [12].
Micromeritic properties of blended powder
Angle of repose
The frictional forces in a loose powder can be measured by the angle of 
repose. Angle of repose is defined as maximum angle possible between 
the surface of a pile of the powder and the horizontal plane. The angle 
of repose was determined by the fixed funnel method. The accurately 
weighed powder was taken in a funnel. Angle of repose was calculated 
using the following equation [13]:
tan θ =  h/r
Where, θ = Angle of repose,
h = Height of the pile, cm
r = Radius of the base of the pile, cm.
Carr’s consolidation index
The Carr’s consolidation index of the powder blend is defined as:




Bulk density is the ratio of mass of powder to the bulk volume. Tapped 
density is the ratios of mass of powder to the tapped volume.
Evaluation of matrix tablets
The tablets were evaluated for their physical properties such as weight 
variation, hardness, and friability.
Weight variation
A total of 20 tablets of each formulation were selected randomly and 
weighed individually using an electronic weighing balance. The average 
weight was calculated and individual tablet weight was compared with 
average weight [14].
Hardness and friability
Hardness studies were carried out by a Monsanto hardness tester. Six 
determinations were carried out for each sample to calculate the hardness 
of prepared tablets. Hardness of tablets was measured in terms of kg/cm2. 
The friability of the tablets was measured using Roche friabilator. 10 tablets 
were weighed accurately, placed in the chamber, and rotated for 4 min 
(100 rotations). At the end, the dust on the tablet were cleaned, weighed 
accurately again and the percent friability was computed from the weight 
of tablets. Friability was calculated using the following equation [15]:





Uniformity of drug content
A total of 10 tablets were weighed from each formulation and 
triturated in mortar to a fine powder. Powder equivalent to 200 mg of 
metronidazole was extracted in 100 ml of 0.1 N hydrochloric acid and 
filtered. The drug content was determined by measuring the absorbance 
of sample using ultraviolet (UV)-visible spectrophotometer (LAB 
INDIA) at 277 nm after appropriate dilution with 0.1 N hydrochloric 
acid. The drug content was determined using calibration curve [16].
Buoyancy lag time determination
The buoyancy of the tablets was studied at 37±0.5°C, in 100 ml 0.1 N 
hydrochloric acid. The time required for the tablet to rise to the surface 
and total floating time was recorded [17].
In vitro dissolution study
Dissolution test of floating matrix tablets of metronidazole was 
performed using a USP type II (paddle) dissolution testing apparatus. 
The rotational speed was set at 50 rpm and the temperature remained 
constant at 37±0.5°C. 900 ml of 0.1 N hydrochloric acid was used as 
dissolution medium. 5 ml aliquots were withdrawn at predetermined 
Table 1: Composition of floating matrix tablets of metronidazole
Composition (mg/tab) Formulation
F1 F2 F3 F4 F5 F6 F7 F8 F9
Metronidazole 200 200 200 200 200 200 200 200 200
HPMCK4M 125 150 175 - - - 62.5 75 87.5
Xanthan gum - - - 125 150 175 62.5 75 87.5
Sodium bicarbonate 65 65 65 65 65 65 65 65 65
MCC 100 75 50 100 75 50 100 75 50
Magnesium stearate 5 5 5 5 5 5 5 5 5
Talc 5 5 5 5 5 5 5 5 5
Total weight 500 500 500 500 500 500 500 500 500
HPMCK4M: Hydroxypropyl methylcellulose, MCC: Microcrystalline cellulose
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time intervals and the same amount of fresh dissolution medium added 
to maintain the sink conditions. The collected samples were filtered 
through a 0.45 µm membrane filter and the concentration of dissolved 
drug was measured at 277 nm using a UV-visible spectrophotometer 
(LABINDIA). Cumulative percentage of drug release was calculated 
using equation obtained from a calibration curve [18].
Kinetic analysis of drug release data
To study the release mechanism of metronidazole from the sustained 
release floating matrix tablets, the in vitro drug release data were fitted 
into the following the mathematical models:
• Zero order  Qt = Q0+ k0 t  (1)
• First order  log C= log C0 – k1t/20303 (2)
• Higuchi  Qt = kh t ½   (3)
• Korsmeyer–Peppas Qt/Qα =kp t n  (4)
• Hixon-Crowell cube root (W01/3 –Wt1/3) = kht  (5).
Where, Q0, Qt, and Qα are the amounts of drug dissolved initially, at time t 
and at time infinite. C0 and C are the concentrations of drug initially 
and at time t, W0 and Wt are the amounts of drug in the pharmaceutical 
dosage form initially and at time t, and k0, k1, kh, and kp refer to the rate 
constants obtained from the linear curves of the respective models. n 
is the diffusional exponent that characterizes the mechanism of drug 
release. The values of the coefficient were calculated using regression 
analysis between log Qt/Qα and log time. The diffusional exponent n 
value was obtained from the slope of the regression equation and kp 
was calculated from antilog of the intercept value.
If the value of n for a cylinder is <0.45, it suggests the Fickian release 
(diffusion controlled), if n >0.45 and <0.89, it is non-Fickian release 
(diffusion and polymer relaxation), 0.89 is Case II release (only 
relaxation and swelling) and >0.89 it suggests super Case II release 
(relaxation and erosion) for swellable systems.
For cylindrical systems like tablets, the n values of 0.45 and 0.89 
represent pure diffusion or erosion release, respectively [19].
RESULTS AND DISCUSSION
Micromeritic properties of blended powder
The powder mixture of all the formulations was evaluated for angle of 
repose, bulk density, tapped density, and compressibility index. Powder 
blend indicated good flow properties with an angle of repose values ranging 
from 29.20±0.82 to 32.08±0.75°. The Carr’s compressibility index for all 
the formulations was found to be between 13.31± 0.3° and 18.77±0.5%.
Evaluation of physical parameters
Sustained release floating matrix tablets of metronidazole were prepared 
by direct compression technique employing varying concentrations of 
HPMCK4, xanthan gum alone, and in combination. The physical properties 
of metronidazole floating matrix tablets were given in Table 2. Sustained 
release floating matrix tablets of metronidazole were prepared by direct 
compression technique. A total of nine formulations were prepared. 
The tablet weight variation, hardness, friability, and content uniformity 
for each formulation are shown in Table 2. The weight variation test 
indicated that the percentage deviation of all tablet formulations was 
found to be within pharmacopoeial acceptable limit. The hardness of 
all the tablets was within the range of 3.32±0.14–4.59±0.15 kg/cm2. 
The percentage weight loss in the friability test was found to be below 
0.8% in all the cases indicated that all the tablets had good mechanical 
strength. The drug content in all the batches was determined by 
measuring the absorbance of sample at 277 nm using double-beam UV 
spectrophotometer (LABINDIA). The content uniformity among different 
formulations was found to be higher and the drug content was more than 
98% which indicates uniform drug distribution in all the formulations.
In vitro floating properties
The in vitro buoyancy studies in simulated gastric fluid revealed good 
buoyancy for all the formulations. Buoyancy lag time for all the tablets 
are shown in table 3 was found to be <2 min. Sodium bicarbonate was 
used as effervescent agent. On contact with the acidic medium, the fluid 
permeates into the tablet, which generates carbon dioxide. The gas 
generated is trapped and protected within the gel, formed by hydration 
of polymer, thus decreasing the density of the tablet. As the density 
of the tablet falls below 1, the tablet becomes buoyant. All the tablets 
(F4–F9) floated in pH 1.2 buffer solution for more than 12 h, except 
formulations with HPMCK4 (F1–F3).
Effect of polymer concentration on matrix integrity of the tablets
Maintenance of matrix integrity of the tablets is an important 
parameter that needs to be studied because if the tablet does not 
maintain its physical integrity, it could be broken down into smaller 
fragments and escape from the gastrointestinal tract. In the present 
study, metronidazole has been formulated into sustained release 
floating tablet to release drug in the gastric environment to show its 
local action in the treatment of peptic ulcer. Buoyancy studies indicated 
that HPMCK4 alone could not maintain matrix integrity up to 12 h and 
disintegrated completely after 6 h as well as rapid erosion of the tablet 
was observed when placed in the dissolution medium due to its low 
viscosity. However, when combined with xanthan gum, it can control 
the release of drug and also matrix integrity was maintained up to 12 h.
In vitro dissolution study
Metronidazole release from the floating matrix tablets was studied for 
12 h in 0.1 N hydrochloric acid. Total nine formulations were made 
with hydroxypropyl methylcellulose K4 and xanthan gum alone and in 
combination. Polymers employed in different ratios, i.e., 1:0.625 (25%), 
1:0.75 (30%), and 1:0.875 (35%). The results of dissolution studies 
indicated that the burst release was observed with hydroxypropyl 
methylcellulose. Sustained release was observed with xanthan gum 
alone and its combination with HPMCK4. Formulation (F4) containing 
25% of xanthan gum as release retardant was selected as best. The 
comparative drug release profiles are given in Fig. 1. Metronidazole 
release from all the matrix tablets was dependent on the concentration 
of release retardant contained in the tablet. The drug release from 
the matrix tablets was decrease as the concentration of release 
retardant was increased. HPMCK4 alone could not control the release 






Hardness* Friability Content 
uniformity
F1 497.30±1.36 3.32±0.14 0.72±0.24 98.23±1.32
F2 499.42±1.13 3.54±0.16 0.69±0.16 99.20±1.28
F3 498.76±1.26 3.58±0.12 0.70±0.18 99.64±1.34
F4 498.90±1.06 4.59±0.15 0.56±0.12 98.26±1.35
F5 498.64±1.32 4.78±0.10 0.66±0.11 99.05±1.34
F6 497.45±1.16 3.46±0.16 0.64±0.13 98.19±1.26
F7 498.82±1.09 4.52±0.14 0.72±0.13 99.56±1.32
F8 499.85±1.28 4.38±0.12 0.69±0.09 98.94±1.23
F9 498.64±1.09 4.22±0.13 0.71±0.10 99.56±1.20
#,*All values are expressed as mean±SD, #n=20 and *n=6. SD: Standard deviation










F1 <1 <12 -
F2 <1 <12 -
F3 <1 <12 -
F4 <2 >12 +
F5 <1 >12 +
F6 <1 >12 +
F7 <2 >12 +
F8 <2 >12 +
F9 <2 >12 +
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of metronidazole from the tablets because the amount of polymer 
was not sufficient to maintain the matrix integrity due to its low 
molecular weight and viscosity. Xanthan gum could control the release 
of metronidazole up to 12 h due to its high molecular weight. These 
results indicate that xanthan gum has higher drug retarding ability than 
HPMCK4. The presence of xanthan gum alone and in combination with 
HPMCK4 retarded the initial release of drug from the tablets due to high 
swelling property.
Drug release kinetics
The release data of matrix tablets were fitted into various mathematical 
models (zero order, first order, Higuchi, ancd Peppas) to evaluate the 
kinetics and mechanism of drug release from the tablets. The model 
that best fits the release data is selected based on the correlation 
coefficient value in various models. The model that gives high R2 value 
considered as the best fit of the release data. The R2 values in zero, first 
order, Higuchi–Peppas, and Hixson-Crowell models are given in Table 4. 
The results indicated that the drug release from the matrix tablets 
followed zero-order kinetics. To evaluate the drug release mechanism 
from the matrix tablets plots of percent drug released versus square 
root of time as per Higuchi’s equation, log time versus log percentage of 
drug release as per Peppas and time versus cube root of drug remained 
as per Hixson-Crowell were constructed. When the release data 
were analyzed as per Peppas equation, the release exponent n value 
Fig. 1: Comparative in vitro dissolution profile of all the formulations mean ± standard deviation, n=3
Fig. 2: (a) Fourier-transform infrared spectroscopy spectrum of pure metronidazole. (b): Fourier-transform infrared spectroscopy 
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was ≤0.89 with all the tablets indicating Case II release, i.e., polymer 
swelling and relaxation might be the mechanism for the drug release 
from the matrix tablets.
Compatibility studies
From the Fourier-transform infrared spectroscopy studies shown in 
Fig. 2, it is very clear that there are no interactions between drug and 
excipients. All the peaks responsible for the active functional groups 
were present in the best formulation (F4). The characteristic and 
observed peaks are mentioned in Table 5.
CONCLUSION
The effervescent floating matrix tablets of metronidazole were 
prepared by direct compression method employing HPMCK4, xanthan 
gum as drug release retardants, and sodium bicarbonate used as gas 
generating agent. The concentration of gas generating agent and release 
retardants considerably affected the buoyancy time, matrix integrity, 
and profile of drug release. Thus, by changing the concentration of gas 
generating agent and polymer in formulations, the characterization 
of the matrix tablets could be controlled. All the formulations showed 
floating lag time <2 min. Xanthan gum alone and in combination with 
HPMCK4 has successfully sustained the release of metronidazole. The 
drug release from the floating matrix tablets was found to be zero-
order kinetics with Case II transport, involves polymer swelling and 
chain relaxation as mechanism of drug release. Floating tablets of 
metronidazole sustained the drug release for 12 h can be expected to 
eradicate H. pylori in peptic ulcer disease.
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